You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 10, October 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Abstract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Pediatrics
 •Pediatrics, Other
 •Public Health
 •World Health
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cutaneous Amebiasis in Pediatrics

Mario L. Magaña, MD; Jorge Fernández-Díez, MD; Mario Magaña, MD

Arch Dermatol. 2008;144(10):1369-1372.

ABSTRACT

Background  Cutaneous amebiasis (CA), which is still a health problem in developing countries, is important to diagnose based on its clinical and histopathologic features.

Observations  Retrospective medical record review of 26 patients with CA (22 adults and 4 children) treated from 1955 to 2005 was performed. In addition to the age and sex of the patients, the case presentation, associated illness or factors, and method of establishing the diagnosis, clinical pictures and microscopic slides were also analyzed.

Conclusions  Cutaneous amebiasis always presents with painful ulcers. The ulcers are laden with amebae, which are relatively easy to see microscopically with routine stains. Erythrophagocytosis is an unequivocal sign of CA. Amebae reach the skin via 2 mechanisms: direct and indirect. Amebae are able to reach the skin if there is a laceration (port of entry) and if conditions in the patient are favorable. Amebae are able to destroy tissues by means of their physical activity, phagocytosis, enzymes, secretagogues, and other molecules.



INTRODUCTION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Cutaneous amebiasis (CA) can be defined as damage to the skin and underlying soft tissues by trophozoites of Entamoeba histolytica, the only pathogenic form for humans. Cutaneous amebiasis may be the only expression of the disease or may involve other organs, usually the gastrointestinal tract.1-2 The liver, lungs, and especially the central nervous system may also be involved.

Other species of Entamoeba, such as Entamoeba hartmanni, Entamoeba coli, and Entamoeba gingivalis, are nonpathogenic.3 Interestingly, another species, Entamoeba dispar, identified by Brumpt in 1925,4 has been recognized as being responsible for many cases of CA in patients previously interpreted as "healthy carriers." Entamoeba dispar is morphologically indistinguishable from E histolytica but genetically and serologically different.5-6

Entamoeba moshkovskii, which is morphologically indistinguishable from E histolytica and E dispar but biochemically and genetically different, has been considered until recently to be primarily a free-living (nonpathogenic) ameba. The early isolates of E moshkovskii were free-living forms found in sewage, but human isolates have now been detected in North America, Africa, Australia, and some parts of Europe.7 The group of amebae known as free-living amebae, Acanthamoeba, Balamuthia, and Naegleria, are opportunistic organisms that act as pathogens, usually in the immunocompromised host, who can develop disease in any organ, such as the skin and central nervous system. This kind of amebiasis has become more common during the last few years.8-18 To determine the forms of presentation of CA in pediatric patients and the mechanisms by which amebae reach the skin, we performed a retrospective study of patients cared for during the last 50 years at 2 major hospitals in Mexico City, Mexico.


METHODS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

All patients with an unequivocal diagnosis of CA based on the clinical and histopathologic identification of trophozoites were retrieved from our files at the Clinic for Pediatric Dermatology of the Hospital General de México and from the Department of Pathology of the Hospital de Especialidades of the Centro Médico Nacional, IMSS, from 1955 to 2005. The clinical information was collected from the clinical records and/or by histopathologic request. Paraffin-embedded blocks that housed skin specimens were recut and stained with hematoxylin-eosin. Slides were prepared to be read under the microscope.

Bacteriologic studies from ulcers and necrotic edges and parasitoscopic analysis from stool samples were performed at the time of presentation for care. Results of these tests were retrieved from patient records. Clinical pictures of all patients were taken before and after treatment.


RESULTS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

There were 22 adults and 4 children (all <2 years old) identified with CA. The constant and common clinical denominator of the 4 children was a putrid, painful ulcer, which ranged from 1 to several perineal ulcers. Ulcers showed a gray-white necrotic base, with red edges, that extended rapidly in diameter and depth, during a period of weeks, at the rate of approximately 1 cm/wk. The ulcer measured from a few millimeters to several centimeters (Figure 1 and Figure 2).


Figure 1
View larger version (80K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. A male child with multiple ulcers by amebiasis in the diaper area.



Figure 2
View larger version (247K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. A female child with amebic dysentery showing 1 painful ulcer.


The 4 pediatric patients were all toddlers using diapers. All these patients had amebic colitis and developed amebic diarrhea. The diaper maintained contact of the trophozoites with the skin. Therefore, the anatomical sites of the ulcers were in the diaper area: anus and perianal area, buttocks, perineal, inguinal folds, and pubis. Patient 1 has been previously described by 1 of us (M.M.) as an example of this disease in children.19

Diagnosis was clinically suspected and confirmed by skin biopsy. Trophozoites of E histolytica were identified as round or oval unicellular basophilic structures, measuring 20 to 50 µm, often surrounded by a clear halo, which is assumed to be tissue retraction due to dehydration,20 and with a nucleus measuring 4 to 7 µm (Figure 3). By performing a smear from the edge of the ulcers, we were to show the amebae in 2 of our patients (patients 1 and 3).


Figure 3
View larger version (64K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. A trophozoite with a red cell inside among inflammatory cells in a cutaneous amebiasis (hematoxylin-eosin, original magnification x400).


At least 1 ulcer that involved the epidermis and dermis to a variable depth was seen. Often there were wide areas of necrosis, with fine granular and eosinophilic bland material with nuclear debris. Surrounding the ulcers was a mixed inflammatory infiltrate of neutrophils, lymphocytes, and eosinophils, generally in association with extravasated erythrocytes. Erythrophagocytosis by amebae was a constant feature in CA and represents a microscopic sign of its pathogenicity. No granulomas are seen in amebiasis.

In all 4 pediatric patients, microscopic examination of the stool sample showed a cyst of E histolytica; cultures of the ulcers yielded Staphylococcus epidermidis and Escherichia coli. Cultures from blood and cerebrospinal fluid yielded no growth of bacteria. In 2 patients (patients 1 and 4), we were able to perform serologic tests in which an enzyme-linked immunosorbent assay reaction was positive for E histolytica.

Chest radiographs from the 4 pediatric patients showed right hemidiaphragm elevation in 2 of them and abdominal radiography confirmed hepatomegaly in those 2, but no other alterations were seen in the 4 pediatric patients.

All these children were treated with dehydroemetine, 1 mg/kg daily for 10 days, and metronidazole, 30 mg/kg daily for 21 days. Escharotomy, cleaning, and dressing changes were performed daily for all patients. This regimen produced rapid improvement in days to weeks, with all ulcers healing by the second week of care. Patient 1, who had the most severe case of CA, was referred to the plastic surgery service for reconstruction of the vulva and perineum. The other 3 children healed without the need for reconstruction.


COMMENT
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Historically, the first patient with amebiasis seems to have been treated in Mexico by Mateo Alemán, the physician of the then archbishop and viceroy of New Spain, who in 1611 presented with "diarrhea followed a few days later by hepatic suppuration."20 Nevertheless, Hippocrates recognized that "dysenteries in association with inflammation of the liver are bad," and in 1875 Lösch described amebic trophozoites in the stool and colonic ulcerations of a man with fatal dysentery.21 However, other authors20 state that the first identification of the parasite associated with diarrhea was made in children by Lamb and that Lösch reproduced the intestinal disease in a dog by means of the feces from an individual with dysentery.

In children CA is rare; when it occurs, it usually, if not always, develops in the anal and perianal area and the genitalia, usually in association with amebic dysentery, as can be deduced from our 4 patients and 9 others mentioned in the literature (Table). Biagi and Martuscelli22 described 3 patients: a male with inguinal involvement and 2 females with vulvar ulcers, 1 of whom died of CA and the other 2 who healed in a 10-day period after treatment with emetine hydrochloride. A 9-month-old boy with lesions on the abdomen died without treatment—the diagnosis was obtained post mortem.23 Alvarez Chacon,24 Wynne,25 and Rimsza and Berg26 each published articles describing a girl with ulcers on the vulva, which healed with medical treatment after approximately 10 days. Two other children with CA were exceptional because of where it developed on one child (on the right periorbital skin27) and in the other because of the child’s age (a 9-year-old) and where it developed (perianal ulcers and diarrhea in the diaper area on child who did not wear diapers).28 Both responded well to medical treatment.


View this table:
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Table. Cutaneous Amebiasis in Pediatric Patients


In general, all these children presented with dysentery, fever (body temperatures, 39°C-40°C), irritability, weight loss, anemia, and leukocytosis. When medical treatment (emetine, dehydroemetine, metronidazole, or diiodohydroxyquinoline) is initiated, CA responds soon and well; however, because of the destructive character of the disease, surgical repair is often needed.

To better understand the pathogenesis of CA, it is convenient to briefly review the life cycle of E histolytica. It consists of 2 stages: the cyst or infective stage and the trophozoites or tissue-invasive stage. The disease is usually acquired by ingesting food or water contaminated with cysts, which are 10 to 25 µm and have 4 nuclei; they are capable of surviving for days outside the body and are also able to survive the acidic environment of the stomach and excyst in the ileum. Each cyst gives origin to 8 trophozoites, which live in the lumen of the colon, where they multiply by binary fission and from where they may invade the intestinal wall and eventually penetrate a blood vessel and spread though the bloodstream, most often to the liver, or they may encyst and produce quadrinucleated cysts after 2 successive nuclear divisions.3, 29 Therefore, amebae reach the skin and develop any of the patterns described herein through 2 mechanisms: direct and indirect transmission of the trophozoites.2

Direct infestation results with the spread from the colon and rectum to anal, perianal, perineal, pubic, or genital skin, which is the mechanism of CA in infants (and is the most common form in adults) and thus deserves special mention not only for its rareness but also because all 4 of our pediatric patients share the same clinical picture with those previously described: they are all younger than 2 years. Cutaneous amebiasis is preceded or accompanied by diarrhea. Because of these patients wear diapers, trophozoites are able to remain in contact for a longer time with the skin surface and, surely the association of diapers with humidity and ammonia due to urine and bacteria due to feces may play an adjuvant role.

Indirect transmission results when the trophozoites invade the intestinal wall, penetrate a vessel, and reach the liver; rarely, trophozoites invade other organs, such as the lung and/or chest wall, and migrate to the skin. However, any other area of the body may be infected via a contaminated hand by scratching.

Although CA is not a common disease, it certainly is still a public health problem in many areas. In Mexico, it was more frequent from 1960 to 1980, when its incidence was estimated to be 1 of every 300 dermatologic patients (children and adults) at the Hospital General de Mexico.30 Most cases observed in Mexico have been treated in this institution, which assists mostly indigent people. Now, it may be less common because metronidazole, emetine, and dehydroemetine are readily and widely available.

Amebiasis is an even more important public health problem than CA. There are 500 million individuals infected with Entamoeba. Although most people are colonized with E dispar, which is not pathogenic, many of those individuals have E histolytica, with or without symptoms. An estimated 40 000 to 100 000 people worldwide die yearly of amebiasis.21 Cutaneous amebiasis should be considered in the differential diagnosis of any ulcer in the diaper area of a child and in other areas such as the abdominal wall (because of a colostomy site, draining of a hepatic abscess, or laparotomy incision). Malnutrition, poor hygiene, and preexisting disease contribute to the development of CA in infants and toddlers.

Lysis and necrosis of the skin (and other tissues) are consequences of the interaction between the host and ameba. The necrosis, probably because of the presence of the parasite itself, is specific to this disease and is similar in any tissue: liver, intestinal wall, or lung.20 Amebae release proteases, collagenase, hyaluronidase, N-acetylglucosaminidase, phospholipase-A, and secretagogues. Amebic motility and phagocytosis of erythrocytes are unquestionable histopathologic signs of pathogenicity,2 seen in all our cases. Experimentally, phagocytosis has not always been found to be related to virulence of E histolytica.31 In addition, amebae are capable of capping, ingesting, or shedding ameba-specific antibodies, which may explain the apparent ineffectiveness of antibodies to limit established infections.32 We hypothesize that CA is a rare, aggressive, and destructive form of the disease because of a more virulent strain or a specific susceptibility of the host.2


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Correspondence: Mario L. Magaña, MD, Centre for Dermatology and Dermatopathology, Viaducto Miguel Alemán 230 y Minería 11800, México, DF, México (dermatopatologia{at}hotmail.com).

Accepted for Publication: January 9, 2008.

Author Contributions: Drs M. L. Magaña, Fernández-Díez, and M. Magaña had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: M. L. Magaña, Fernández-Díez, and M. Magaña. Acquisition of data: M. L. Magaña, Fernández-Díez, and M. Magaña. Analysis and interpretation of data: M. L. Magaña, Fernández-Díez, and M. Magaña. Drafting of the manuscript: M. L. Magaña, Fernández-Díez, and M. Magaña. Critical revision of the manuscript for important intellectual content: M. L. Magaña, Fernández-Díez, and M. Magaña. Statistical analysis: M. L. Magaña, Fernández-Díez, and M. Magaña. Obtained funding: M. L. Magaña, Fernández-Díez, and M. Magaña. Administrative, technical, or material support: M. L. Magaña, Fernández-Díez, and M. Magaña. Study supervision: M. L. Magaña, Fernández-Díez and M. Magaña.

Financial Disclosure: None reported.

Role of the Sponsors: The sponsors had no role in the design and conduct of the study, in the collection, analysis, and interpretation of data, or in the preparation of the manuscript, review, or approval of the manuscript.

Author Affiliations: Hospital General de México and School of Medicine, Universidad Nacional Autónoma de México (Drs M. L. Magaña and M. Magaña), and Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (Dr Fernández-Díez), Mexico City, Mexico.


REFERENCES
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

1. Magaña ML, Magaña GM. Cutaneous amoebiasis. In: Canizares O, Harman R, eds. Clinical Tropical Dermatology. 2nd ed. Boston, MA: Blackwell Scientific Publications; 1992:278-282.
2. Magaña M, Magaña LM, Alcántara A, Pérez-Martín MA. Histopathology of cutaneous amebiasis. Am J Dermatopathol. 2004;26(4):280-284. FULL TEXT | ISI | PUBMED
3. Martìnez-Palomo A, Ruiz-Palacios G. Amebiasis. In: Warren KS, Mahmoud AAF, eds. Tropical and Geographical Medicine. New York, NY: McGraw-Hill; 1991:327-344.
4. Brumpt ME. Etude sommarie de l’Entamoeba dispar n. sp. Amibea a kystes quadrinuclee, parasite de l’homme. Bull Acad Med (Paris). 1925;94:943-952.
5. Bracha R, Diamond LS, Ackers JP; et al. Differentiation of clinical isolates of Entamoeba histolytica by using specific DNA probes. J Clin Microbiol. 1990;28(4):680-684. FREE FULL TEXT
6. Sánchez-Guillén MC, Pérez-Fuentes R, Salgado-Rosas H; et al. Differentiation of Entamoeba histolytica/Entamobea dispar by PCR and their correlation with humoral and cellular immunity in individuals with clinical variants of amebiasis. Am J Trop Med Hyg. 2002;66(6):731-737. ABSTRACT
7. van Hal SJ, Stark DJ, Fotedar R; et al. Amoebiasis: current status in Australia. Med J Aust. 2007;186(8):412-416. ISI | PUBMED
8. Schuster FL. Cultivation of pathogenic and opportunistic free-living amebas. Clin Microbiol Rev. 2002;15(3):342-354. FREE FULL TEXT
9. Blessmann J, Van Linh P, Nu PA; et al. Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam. Am J Trop Med Hyg. 2002;66(5):578-583. ABSTRACT
10. Healy JF. Balamuthia amebic encephalitis: radiographic and pathological findings. Am J Neuroradiol. 2002;23:486-489. FREE FULL TEXT
11. Galarza M, Cuccia V, Sosa FP; et al. Pediatric granulomatous cerebral amebiasis: a delayed diagnosis. Pediatr Neurol. 2002;26(2):153-156. FULL TEXT | ISI | PUBMED
12. Shenoy S, Wilson G, Prashanth HV; et al. Primary meningoencephalitis by Naegleria fowleri: first reported cases from Mangalore, South India. J Clin Microbiol. 2002;40(1):309-310. FREE FULL TEXT
13. Torno MS, Babapour R, Gurevith A; et al. Cutaneous acanthamoebiasis in AIDS. J Am Acad Dermatol. 2000;42(2, pt 2):351-354. FULL TEXT | ISI | PUBMED
14. Migueles S, Kumar P. Primary cutaneous Acanthamoeba infection in a patient with AIDS. Clin Infect Dis. 1998;27(6):1547-1548. ISI | PUBMED
15. Recavarren-Arce S, Velarde C, Gotuzzo E; et al. Amoeba angeitic lesions of the central nervous system in Balamuthia mandrilaris amoebiasis. Hum Pathol. 1999;30(3):269-273. FULL TEXT | ISI | PUBMED
16. Hunt SJ, Reed SL, Mahews WC; et al. Cutaneous Acanthamoeba infection in the acquired immunodeficiency syndrome: response to multidrug therapy. Cutis. 1995;56(5):285-287. ISI | PUBMED
17. Helton J, Loveless M, White CR. Cutaneous Acanthamoeba infection associated with leukocytoclastic vasculitis in an AIDS patient. Am J Dermatopathol. 1993;15(2):146-149. ISI | PUBMED
18. Paltiel M, Powell E, Lynch J, Baranowski B, Martins C. Disseminated cutaneous acanthamebiasis: a case report and review of the literature. Cutis. 2004;73(4):241-248. ISI | PUBMED
19. Magaña-Garcia M, Arista VA. Cutaneous amebiasis in children. Pediatr Dermatol. 1993;10(4):352-355. ISI | PUBMED
20. Brandt H, Pérez-Tamayo R. Pathology of human amebiasis. Hum Pathol. 1970;1(3):351-385. PUBMED
21. Stanley SL. Amoebiasis. Lancet. 2003;361(9362):1025-1034. FULL TEXT | ISI | PUBMED
22. Biagi F, Martuscelli AR. Cutaneous amebiasis in Mexico. Int J Dermatol. 1963;2:129-136. FULL TEXT
23. Poltera AA. Pseudomalignant cutaneous amebiasis in Uganda. Trop Geogr Med. 1973;25(2):139-141. ISI | PUBMED
24. Alvarez Chacon R. Cutaneous amebiasis. Mod Probl Paediatr. 1975;17:259-261. PUBMED
25. Wynne JM. Perineal amebiasis. Arch Dis Child. 1980;55(3):234-236. FREE FULL TEXT
26. Rimsza ME, Berg R. Cutaneous amebiasis. Pediatrics. 1983;71(4):595-598. FREE FULL TEXT
27. Báez Mendoza J, Ramírez-Barba EJ. Cutaneous amebiasis of the face: a case report. Am J Trop Med Hyg. 1986;35(1):69-71. FREE FULL TEXT
28. Kenner BM, Rosen T. Cutaneous amebiasis in a child and review of the literature. Pediatr Dermatol. 2006;23(3):231-234. FULL TEXT | ISI | PUBMED
29. Li E, Stanley SL. Parasitic disease of the liver and intestines (amebiasis). Gastroenterol Clin. 1996;25:471-489. FULL TEXT
30. Magaña ML. Amibiasis cutánea. Rev Méd Hosp Gral Méx. 1980;43:33-36.
31. Montfort I, Pérez-Tamayo R. Is phagocytosis related to virulence in Entamoeba hystolytica Schaudin, 1903? Parasitol Today. 1994;10(7):271-273. FULL TEXT | ISI | PUBMED
32. Calderón J, Muñóz ML, Acosta MH. Surface redistribution and release of antibody-induced caps in Entamoeba. J Exp Med. 1980;151(1):184-193. FREE FULL TEXT


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Dermatology
Arch Dermatol. 2008;144(10):1271.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.